Integra LifeSciences Holdings Corporation
IART
$15.10
-$0.02-0.13%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -1,612.25% | -7,337.70% | -7,468.14% | -2,217.00% | -171.97% |
| Total Depreciation and Amortization | 3.77% | 7.76% | 24.30% | 27.71% | 19.99% |
| Total Amortization of Deferred Charges | -6.54% | 0.21% | 6.47% | 5.29% | -1.62% |
| Total Other Non-Cash Items | 4,156.72% | 2,025.76% | 2,149.17% | 1,149.37% | -54.23% |
| Change in Net Operating Assets | -22.89% | -8.80% | -240.26% | -10.56% | 48.15% |
| Cash from Operations | -30.21% | -61.06% | -35.00% | -49.97% | -20.98% |
| Capital Expenditure | 42.85% | 22.01% | 5.57% | -30.84% | -71.76% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | 101.48% | 101.48% | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -185.63% | -210.37% | 119.59% | 141.82% | 134.83% |
| Cash from Investing | 76.66% | 72.35% | 82.56% | 83.63% | -177.27% |
| Total Debt Issued | 317.14% | 48.14% | 50.52% | -78.50% | -67.57% |
| Total Debt Repaid | -268.57% | -257.98% | -298.37% | 39.82% | -65.29% |
| Issuance of Common Stock | -20.59% | -85.04% | -85.55% | -86.85% | -88.59% |
| Repurchase of Common Stock | 96.08% | 94.79% | 89.96% | 97.00% | 57.29% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -23.36% | -72.06% | -66.73% | -66.12% | -4,724.92% |
| Cash from Financing | 101.47% | -88.09% | -101.33% | -106.16% | -129.32% |
| Foreign Exchange rate Adjustments | 296.20% | 378.73% | -14.59% | 675.81% | 250.57% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 99.35% | 62.28% | 129.07% | 102.85% | -223.99% |